Canada markets closed

Applied Therapeutics, Inc. (APLT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
11.48+0.70 (+6.49%)
At close: 04:00PM EST
11.55 +0.07 (+0.61%)
After hours: 04:22PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close10.78
Open10.68
Bid9.79 x 900
Ask11.51 x 1200
Day's Range10.13 - 11.51
52 Week Range10.13 - 29.80
Volume118,616
Avg. Volume89,855
Market Cap300.954M
Beta (5Y Monthly)0.91
PE Ratio (TTM)N/A
EPS (TTM)-4.14
Earnings DateNov. 12, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est44.50
  • GlobeNewswire

    Applied Therapeutics to Present at the 14th International Congress of Inborn Errors of Metabolism

    NEW YORK, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, has announced a symposium and poster presentations at the 14th International Congress of Inborn Errors of Metabolism (ICIEM), November 21-23, 2021, Sydney, Australia. “We are pleased to present this important data at the ICIEM conference, demon

  • Simply Wall St.

    Great news for Applied Therapeutics, Inc. (NASDAQ:APLT): Insiders acquired stock in large numbers last year

    Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...

  • GlobeNewswire

    Applied Therapeutics Reports Third Quarter 2021 Financial Results

    Data from pilot trial of AT-007 in SORD deficiency expresses substantial and significant reduction in sorbitol Data from the ACTION-Galactosemia Kids study demonstrates statistically significant reduction in plasma galactitol NEW YORK, Nov. 12, 2021 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today reported fin